I am a physician and medical writer with 16 years of experience. I was in clinical practice as a neurologist for 10 years before becoming a medical consultant to the pharmaceutical and healthcare industry.
Read More »
I was a clinical instructor at the NYU School of Medicine for 5 years. I have written research protocols and presented the results at national medical conferences. I was on the Speaker's Bureau of Novartis, Eli-Lilly and Shire Pharmaceuticals. i have published 8 articles in medical journals and 4 chapters in textbooks.
I am currently...
Dec 26, 2013|Academic Writing|$358|Completed
Dec 17, 2013|Article Writing|$45|Completed
Nov 25, 2013|Other - Writing Services|$500|Completed
Nov 25, 2013|Other - Writing Services|$121|Completed
Ross B. FineSmith M.D.
31 Parkview Ave
Basking Ridge, New Jersey 07920
Pharmaceutical Industry Experience
Medical and Neurology Consulting (January 2004-Present).
Private consulting business solutions to pharmaceutical firms
Develop drug and medical device research protocols.
Provide and edit regulatory documents. Specializing in CERís.
Write chapters and e-books on neurology related chapters.
Provide power point presentations for medical liaison divisions in pharmaceutical companies.
Provide guidance to medical marketing firms using e-detailing to target physicians.
MedSci (February 2010-Present)
Edit and prepare neurology manuscripts for publication.
BioEdit. (Janurary 2012-Present)
Edit and prepare scientific manuscripts for publication
Healthline Medical Review and Advisory Board (August 2013-Present)
Novartis Pharmaceutical Company (December 2002- January 2005). Participated in educational seminars for company neurology pharmaceutical representatives.
Shire Pharmaceuticals (August 1998-January 2005). Presenter on Speakers Bureau. Presentations to doctors groups and organizations. Discussed pharmacokinetics of Adderall XR and medication strategies to more successfully utilize the medication.
Lilly Pharmaceuticals (May 2001- January 2005). Presenter on Speakers Bureau. Presentations to doctors groups and organizations. Discussed pharmacokinetics of Strattera and...
Read More »